Revibe

High-Level Overview

Revibe Technologies is a digital therapeutics company developing wearable technology to treat attention and focus challenges, primarily for ADHD and Autism, by fusing behavioral science with AI-driven smartwatches that deliver personalized vibration reminders.[1][2][6] The product serves children, students, adults, educators, clinicians, and caregivers, solving issues like distraction in classrooms and workplaces through discreet, data-tracking interventions that enhance self-regulation and provide actionable insights via an app dashboard.[2][6][7] Formerly FokusLabs, founded in 2013, it has sold over 40,000 units, collected 10 million hours of user data, and recently launched via Pearson partnership using Samsung Galaxy Watch7 hardware as of October 2025, marking strong growth momentum in the digital health space.[1][3][7]

Origin Story

Revibe Technologies was founded in 2013 by school psychologist Rich Brancaccio in Wake Forest, North Carolina, after observing students struggle with focus despite their potential, inspiring him to create a tech solution blending psychology and wearables.[1][2][6][7] Initially launched as an over-the-counter wearable, it gained early traction with over 40,000 units sold to parents and 10 million hours of child usage data, evolving from FokusLabs Behavioral Solutions into Software as a Medical Device (SaMD) for ADHD and neurological conditions.[1][3] Key leadership includes CEO Joseph Koziak, an entrepreneurial producer in pharmaceuticals and digital therapeutics, with pivotal moments like the 2023 Prix Galien Award nomination and 2025 Pearson acquisition/launch expanding its reach.[1][3][7]

Core Differentiators

Revibe stands out in digital therapeutics through these key features:

• AI-Powered Personalization: Uses machine learning on Samsung hardware to deliver optimized vibration/text reminders, adapting to individual behavior patterns for focus enhancement, while tracking metrics like on-task time, fidgeting, steps, and self-reports.[1][4][6][7]
• Dual Active/Passive Data Collection: Wearable sensors and user taps generate historical/predictive analytics, offering clinicians and educators real-time dashboards for tailored interventions without stigma.[6][7]
• Proven, Scalable Hardware Integration: Leverages Samsung Galaxy Watch7 with Knox security for reliability, transitioning from proprietary OTC devices to a clinician-backed platform via Pearson.[6][7]
• Behavioral Science Fusion: Combines psychology expertise with therapeutics, showing real-world efficacy in CNS Summit presentations and award nominations, targeting ADHD/Autism with non-pharmacological support.[1][2][4]

Role in the Broader Tech Landscape

Revibe rides the digital therapeutics and wearable health boom, capitalizing on rising ADHD diagnoses (affecting millions) and demand for non-drug alternatives amid mental health crises post-pandemic.[1][7] Timing aligns with AI advancements in personalized medicine and partnerships like Pearson-Samsung, enabling scalable SaMD amid regulatory progress for wearables.[3][6][7] Market forces favoring it include exploding edtech/healthtech integration, data-driven insights for education, and investor interest from funds like The Launch Place and RTP Capital, influencing the ecosystem by democratizing focus tools and providing 10M+ hours of behavioral data for future neurotech R&D.[3][4]

Quick Take & Future Outlook

Revibe's Pearson-backed launch positions it for explosive adoption in schools and clinics, potentially expanding to broader CNS conditions with its vast dataset fueling AI refinements.[1][3][7] Trends like AI wearables for mental health and self-regulation will propel growth, evolving its influence from niche ADHD aid to mainstream learning enhancer. As distractions intensify, Revibe could redefine accessible therapeutics, building on its founder-inspired origins to level the playing field for focus-challenged users worldwide.[2][7]